How do you integrate HIV (+) serostatus into a patient's ASCVD if they would not otherwise qualify for a statin either for primary or secondary prophylaxis?

As seen in this published work: Craig Beavers, Alice K. Pau, David Glidden, et al. Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel. Ann Intern Med.2025;178:847-857. [Epub 27 May 2025]. doi:10.7326/ANNALS-24-03564

Answer from: at Academic Institution

HIV (+) serostatus is a significant risk-enhancer for the development of cardiovascular disease and should be taken into account when making treatment decisions regarding statin initiation, even if the patient's viral load is low or not detectable. In a patient >40 years old and with a risk >5...

Comments

at Providence Health & Services - Oregon/St Vincent Hospital and Medical Center
@Audrey E. Metz, I find the in-between zone (i.e.,...

Please select the option that best describes you:

How do you integrate HIV (+) serostatus into a patient's ASCVD if they would not otherwise qualify for a statin either for primary or secondary prophylaxis?

Related Questions